Good news comes in twos for Topcon

Topcon Medical Systems has received FDA approval for its 3D OCT-1000. Meanwhile, the firm has also announced that it is to become the sole European distributor of OptiMedica's Pascal Photocoagulator.

The 3D OCT-1000 is the first Fourier-domain optical coherence tomography (OCT) with a colour, non-mydriatic retinal camera. It is designed to provide high-resolution cross sectional imaging of the retina to aid in the diagnosis and monitoring of various pathologies, including retinal detachments, macula holes, age-related macular degeneration and glaucoma.

Topcon has also entered into an agreement with OptiMedica whereby Topcon Europe Medical B.V., the European subsidiary of the Topcon Corporation, is to become the exclusive distributor of the Pascal Photocoagulator in key European markets.

The Pascal (Pattern Scan Laser) Photocoagulator is a device that has been designed to optimize the treatment of eye diseases by applying a predetermined pattern array of up to 56 laser spots to the retina within 0.6 seconds.